RE:Bottom Line: xB3 never in a stronger positionpoof, Biodexa has stated that they will not retain control of the xB3 platform.
It's not a selling point for the deal.
Why are you pumping the enemy's company, owned 75% by Ladenburg Thalmann people?
It's embarrassing. You pass yourself off as a market guru but you are driven only by your current trade and/or income source.
jd